chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 11-Feb-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 11-Feb-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 11-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 11-Feb-2022) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.  On 11-Feb-2022 at 1:10 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 11-Feb-2022 at 1:10 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 11-Feb-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 11-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 11-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 11-Feb-2022) outcome was unknown.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Dosage text was reported as additional dose.  The patient received vaccine past its 30-day expiry date on 11-Feb-2022 at 1:10:35 PM.  Vaccine went into 2 to 8 degree Celsius thaw state on about 24-Dec-2021. The vaccine was administered up until its manufacturing expiry date of 04-Apr-2022.  Treatment information was not provided.   This case was linked to MOD-2022-542869 (Patient Link).
Case number PHEH2016US029955, is an initial spontaneous report received from a consumer on 10 Nov 2016. This report refers to a 48 years old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with a single dose of FLUCELVAX Quadrivalent (batch number: 185285, expiry date: Apr 2017) at a dose of 0.5 ml intramuscularly on 06 Nov 2016. On 08 Nov 2016, the wife of reporter experienced itching all over and hives on back. The patient was treated with Hydrocortisone to treat hives. The outcome of the events was reported as condition improving. The seriousness of the events was reported as non serious by the consumer. The causality of the events was not reported.
first dose January 2019, can't find record of second dose; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in January 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The patient self reported the case. The age at vaccination was not applicable to this report. The patient could not find any record of having received his/her second dose, which led to incomplete course of vaccination. The patient wanted to know that can he/she go to my pharmacy and get the second dose now or have to start over. The follow up would not be possible as no contact details were available.
First just feverish, chills, headache but on the morning of 4/22 at 6:50 a.m., I passed out while I was teaching online. I grazed my nose, but I was sitting in a chair at the time.  I felt dizzy before the episode and very hot. I have fainted before many years ago, so it was a similar feeling.
About 8 hours after getting the vaccine, I got a headache , chills and body aches that lasted about 12 hours.
Sore left arm, day 2.  Swelling, redness, inflamation (heat), itching on day 8- a week after the injection.  This required Acetaminophen and  cortisone cream.  Surface area (4" by 6") still red on day 10.
Per Client received first COVID 19 vaccine on 1/23/2021 and had mild symptoms, fatigue and arm soreness. Per Client after receiving the second COVID 19 vaccine on 2/12/2021 started having symptoms  of swollen, painful and tender Lymphnode  in left armpit area, on 2/14/2021 at 0830. Per Client having difficulty lowering left arm completely. Client also C/O having sever achy pain over the left Trapezius muscle, makingit difficulty to drive. Per Client has been taking Ibuprofen for pain and placed a called to PCP for follow up only. Per Client pain listed above has not resolved as of today.
MENACTRA and Hep A (HAVRIX Peds) vaccines given at 1254. Patient states she hot and thirsty about 10 seconds after these vaccinations. Patient get a little diaphoretic but denies dizziness/fainting. Water and sucker given and patient states she feels fine after drinking water and sucker. Advised pt. to go home and eat lunch and drink fluids.
got shingles after the first dose of shingrix; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had shingles. The reporter did not consent to follow up. The reporter did not want to provide data because he said he had already reported it but no report was found.
Initial and follow up information has been received from a certified medical assistant (CMA), concerning a 16 year old female patient, who on 20-DEC-2006 was vaccinated IM in the arm, with the second dose, 0.5ml, of Gardasil (Lot # not provided). The CMA reported that the patient was "late" with receiving the vaccination, and added that the patient complained that "the medicine burned." At the time of this report, the patient had recovered from the event (date and duration not specified). The patient sought unspecified medical attention. The CMA reported other "young teenaged" patients also experienced the medicine burning when vaccinated with Gardasil (lot # not provided) (WAES #0708USA01332). Additional information is not expected.
Pt presented at the nurses office with nausea, dizziness and a headache. BP 95/66. Rested-home with mother @ 1pm. Starting to feel better at that time.
This report describes the occurrence of headache in a 30 y.o. female who was vaccinated w/Hep B vaccine (brand unknown) for prophylaxis. This report was received from a subject and has not been verified by a physician or other health care professional. Medical history, concurrent conditions, and concurrent medications were not reported. The subject experienced no adverse events following previous immunizations. On 10/9/02, the subject reportedly received her 3rd injection of Hep B vaccine (brand unknown). The injection was reportedly administered intradermally. The prescribing info. for Engerix-B recommends that injections of Engerix-B be administered via the intramuscular route. The subject reported that on 10/10/02 she experienced a headache and inject site swelling. She stated that she consulted a health care prof'l regarding the events.
Pt vaccinated with MMR/Haemophilus developed petechiae, bleeding from gums, bruising started about 7OCT90.
p/vax pt started running fever of 102.8 in the early am;mom contacted MD;pt exp stomach cramp;lost of oz;
Headache-dull/ site pain - at 12 hrs post injection Chills 18 hrs post injection Fever 38C - 30 hrs post Injection Significant fatigue
Information has been received from a consumer concerning her 18 year old daughter with a history of asthma and allergy to cefixime (SUPRAX) and cefaclor (CECLOR) who in February 2007, was vaccinated with the first dose of GARDASIL vaccine (yeast) (lot number not provided). On unspecified dates the patient receive the second and third dose of GARDASIL vaccine (yeast) (lot number not provided). Concomitant therapy included albuterol. The caller reported that her daughter's arm swelled up and she experienced severe sweating, paleness, nausea and a fever approximately 1 1/2 hours after receiving her first dose of GARDASIL vaccine (yeast). These symptoms lasted for 24-30 hours. She experienced these same symptoms after her second dose of GARDASIL vaccine (yeast) however they took less than 1 1/2 hours to appear and lasted for 24 hours. These same symptoms appeared quickly after the third dose and lasted 12-15 hours. Unspecified medical attention was sought with several physicians. On an unspecified date the patient recovered. Additional information  has been requested.
Little bleeding in the nose; Chest pains on both sides, right side more than the left side of the chest; Arm soreness; Fever; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (Little bleeding in the nose), CHEST PAIN (Chest pains on both sides, right side more than the left side of the chest), VACCINATION SITE PAIN (Arm soreness) and PYREXIA (Fever) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Nov-2021, the patient experienced EPISTAXIS (Little bleeding in the nose). In November 2021, the patient experienced CHEST PAIN (Chest pains on both sides, right side more than the left side of the chest), VACCINATION SITE PAIN (Arm soreness) and PYREXIA (Fever). At the time of the report, EPISTAXIS (Little bleeding in the nose), CHEST PAIN (Chest pains on both sides, right side more than the left side of the chest), VACCINATION SITE PAIN (Arm soreness) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 17-Nov-2021: Follow up received and contains Non significant information.
fighting for his life; Initial information received on 18-Oct-2021 regarding an unsolicited valid non-serious case received from a consumer via social media.  This case involves an unknown age male patient who experienced fighting for his life (unevaluable event) after receiving INFLUENZA VACCINE.  Medical history, past medical treatment, past vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious fighting for his life (unevaluable event) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "wow good luck! My dad is fighting for his life after getting the vaccine!!!"  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the event outcome reported as unknown for the event.  There will be no information available on batch number for this case.
This spontaneous report as received from a Medical Assistant refers to a 12 year old male patient. The patient's medical history, concurrent condition and concomitant medications were not reported. On 28-SEP-2017 the patient was vaccinated with improperly stored dose of GARDASIL 9 from lot N017697 expiry date 21-JAN-2020 by intramuscular route for prophylaxis. No adverse events reported. The call was made due to a digital data logger. The vaccine was exposed to a temperature of 50.5 degrees Fahrenheit for a time frame of 1.5 hours. There was no previous temperature excursion involved. This is one of the several reports linked via same reporter link. Sender's Comments: US-009507513-1711USA004678: US-009507513-1711USA004679: US-009507513-1711USA004680: US-009507513-1711USA004678: US-009507513-1711USA004676: US-009507513-1711USA004805.
Systemic: Seizure-Mild, Additional Details: Patient has dysautonomia but her Doctor reccommended she get the COVID vaccine>  She had no problem with flu vaccine but did have a seizure after Tdap.  She had a mild seizure within minutes of vaccine then had 2 more so 911 was called and paramedics took her to hospital.
Per patient on the day he received the vaccine he was preparing dinner about 4-5 hours after receiving it. He experienced a tightness in his throat. He called his daughter who happens to be a pharmacist. She recommended he take BENADRYL. After following her advice, he started to feel better about an hour later.
Arm pain throughout the day that worsened (couldn?t lift up arm past 45 degrees)  and at night I had muscle aches all over my body. I felt cold and feverish though did not have a fever. Took 1 g of Tylenol which helped chills and muscle aches. This morning (next day) I am still having muscle soreness so I will probably take another 1 g of Tylenol.
Vomiting, Hematemesis, Coughing, Ocular Hyperemia
Wheezing; Coughing; Mass in her lungs; This spontaneous case was reported by a consumer and describes the occurrence of WHEEZING (Wheezing), COUGH (Coughing) and PULMONARY MASS (Mass in her lungs) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WHEEZING (Wheezing), COUGH (Coughing) and PULMONARY MASS (Mass in her lungs). At the time of the report, WHEEZING (Wheezing), COUGH (Coughing) and PULMONARY MASS (Mass in her lungs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided by reporter. No treatment information was provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 17-Aug-2021: Follow-up included no new information.
She felt unstable and felt like she might pass out; swelling of my tongue and cheeks; swelling of my tongue and cheeks; cold rush throughout my body; hot flash; This is a spontaneous report from a contactable consumer (patient). A 58-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (at 58 years of age), dose 2 via an unspecified route of administration, administered in arm left on 06Apr2021 09:45 (Batch/Lot Number: ER8734) as a single dose for COVID-19 immunisation. Medical history included acid reflux, pre type II diabetes, Hashimoto's disease and possible Sjogrens; she was allergic to shellfish and berries. The patient had unspecified concomitant medications. The patient previously took and had allergies to sulfur, epinephrine and lidocaine. Historical vaccine included PFIZER BIONTECH COVID 19 VACCINE (lot number EN6207) (at 58 years of age), dose 1 in the left arm on 16Mar2021 for COVID-19 immunisation. The patient was not pregnant. The patient had no covid prior vaccination. She has not been tested post vaccination. It was reported that on 06Apr2021 10 AM, after just 13 minutes (as reported) of the shot, the patient experienced swelling of her tongue and cheeks along with a cold rush throughout her body followed by a hot flash. She felt unstable and felt like she might pass out. The events resulted in Emergency room/department or urgent care. Therapeutic measures were taken as a result of the events- treatment included BENADRYL day 1 and Prednisone added day 2. The patient was recovering from the events.
Patient has been having a lot of retching.  He has a Nissan so he can't vomit.  No diarrhea. Mother has been venting the G-tube frequently.
Subcutaneous administration  of both vaccines leading to possible vaccine failure and need to repeat at least the flu vaccine.
Symptoms similar to what "I" experienced when "I" had COVID. Hot flashes with high frequencies; Feel nauseated; Severe headache; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 22Apr2021, at 09:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19.Patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included hyaluronic acid/glucosamine sulfate/gelatine hydrolysate/ chondroitin sulfate sodium (GLUCOSAMINE CHONDROITIN), amoxicillin (MANUFACTURER UNKNOWN) and collagen (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021, at 02:00 the patient experienced symptoms similar to what she experienced when she had COVID, hot flashes with high frequencies, that made her feel nauseated and severe headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hot flashes with high frequencies, that made the patient feel nauseated and severe headache were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Vomiting, diarrhea 3 days after vaccine and continued through 2/24/15.
Extreme pain and loss of range of motion in left arm/shoulder.  Doctor 12/6, and subsequently on 12/17 after symptoms did not get better.  Cortisone shot on 12/17.  Prednisone prescribed  this week.
Dizziness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient received BNT162b2 (BNT162B2), on 30Jun2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 66 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (DOSE 1, SINGLE), administration date: 28Dec2020, when the patient was 64-year-old, for COVID-19 Immunization; BNT162b2 (DOSE 2, SINGLE; Lot: EL3248), administration date: 18Jan2021, when the patient was 64-year-old, for COVID-19 Immunization; BNT162b2 (DOSE 3 (BOOSTER), SINGLE ; Lot: FC3182), administration date: 28Aug2021, when the patient was 65-year-old, for COVID-19 Immunization; Flu vaccine (Has gotten the flu vaccine, pneumonia vaccine and no reactions that she can remember, nothing extreme); Pneumonia vaccine (Has gotten the flu vaccine, pneumonia vaccine and no reactions that she can remember, nothing extreme). The following information was reported: DIZZINESS (non-serious) with onset 30Jun2022, outcome "not recovered". Therapeutic measures were not taken as a result of dizziness.  Additional information: Dizziness started same day she received the vaccination. Was very pronounced at first and the first couple of days, it was very pronounced. Outcome is still going on and has varied in intensity. Had stayed about the same and when it happens, it lasts for a couple of seconds, then it is gone. Sometimes, it depends on how she moves her head. If she shifts her head really fast, she gets dizzy.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient was nauseous, threw up slightly and had a headache.  This lasted for about 30 minutes, which occurred about 15 minutes after the vaccine administration.  She also had a headache that persisted through till the next day,
Pt reported on 01/26/21 that on the night of 01/22/21 he started having Left Flank pain and muscle spasms. On Saturday 01/23/21 symptoms continued as well as onset of dry cough, chest heaviness, sinus pressure. On Sunday 01/24/21 all symptoms seemed to have resolved. On 01/25/2021 and 01/26/2021 Pt continues to have chest tightness, and left flank pain.
7PM 15SEP92 t104.9, irritability; seen in ER dx URI; rx APAP; 12PM 16SEP92 rash over entire body; 17SEP92 seen by MD dx vax reaction;
About 8 hours after dosage I experienced Heart palpitations, tachycardia, GI pain, nausea, severe flu symptoms such as fever, shivering, joint pain and muscle tenderness. Dizzy and lightheaded. This lasted about 18 hours. All symptoms started to subside but GI pain and increased heart rate/chest pain remains
On Sunday March 28th I started to have allergic reaction. I started to itch all over my body  and broke out into rash  on my stomach. I have been taking Benadryl twice a day since.  Symptoms are gradually getting better.
Pt recvd vax & 1-2 hrs p/vax exp pruritus, swelling, lump @ inject site & lightheadedness; sx lasted 10 days;
Pt c/o "tongue feeling thick" while sitting in observation area after receiving the Covid vaccine. No shortness of breath, chest pain or trouble breathing. No drooling or trouble swallowing.
Approximately 1/2 hr. after receiving vaccine pt. developed hives.  Pt. put on RONITIDINE & BENADRYL.
12 year old patient received 1st dose of Pfizer COVID Vaccine. After receiving the vaccine and waiting the 15 minutes, the patient and her father left the pharmacy area and began to shop in the store. While walking the patient stated that her stomach was hurting and she felt her eyes "look up and then down" and then she started to fall. Her father was able to catch her before falling and carried her back towards the pharmacy area. Patient was able to walk before completely reaching the pharmacy area. Once she was in the pharmacy area, the pharmacist was about to administer another vaccine heard a member state that she would call 911 for the patient. After then the pharmacy went over to the patient and her father and noticed the patient was sweating and immediately gathered a cool compress and provided care to the patient. Patient stated that she received her shot on an empty stomach and the father went to get the patient food. EMT were called and arrived and asked patient a series of questions in which the patient was able to respond to. After about 30-45 minutes, patient had eaten and stated that she felt better and her and father left the pharmacy.
Red circular rash approximately 2 inches across about one-half to one inch below injection site and warm to touch.